User profiles for Patrick Flamen
Patrick FlamenInstitut Jules Bordet Verified email at bordet.be Cited by 9762 |
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
P Flamen, A Lerut, E Van Cutsem… - Journal of Clinical …, 2000 - ascopubs.org
PURPOSE: A prospective study of preoperative tumor-node-metastasis staging of patients
with esophageal cancer (EC) was designed to compare the accuracy of 18-F-fluoro-deoxy-d-…
with esophageal cancer (EC) was designed to compare the accuracy of 18-F-fluoro-deoxy-d-…
[PDF][PDF] Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic …
…, M Paesmans, JL Van Laethem, P Flamen - J Clin Oncol, 2010 - afpremed.org
Purpose Liver dissemination is a major cause of mortality among patients with advanced
colorectal cancer. Hepatic intra-arterial injection of the-emitting isotope yttrium-90 (90Y) bound …
colorectal cancer. Hepatic intra-arterial injection of the-emitting isotope yttrium-90 (90Y) bound …
[HTML][HTML] Bone health in cancer: ESMO clinical practice guidelines
Highlights • The clinical course of advanced cancer for many patients with bone metastases
can be transformed through optimum multidisciplinary management. • Bone-targeted agents …
can be transformed through optimum multidisciplinary management. • Bone-targeted agents …
Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on …
T Lerut, P Flamen, N Ectors, E Van Cutsem… - Annals of …, 2000 - journals.lww.com
Objective To assess the value of positron emission tomography with 18 fluorodeoxyglucose
(FDG-PET) for preoperative lymph node staging of patients with primary cancer of the …
(FDG-PET) for preoperative lymph node staging of patients with primary cancer of the …
[HTML][HTML] EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
…, M Konijnenberg, M Cremonesi, P Flamen… - European journal of …, 2022 - Springer
Primary liver tumours (ie hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma
(ICC)) are among the most frequent cancers worldwide. However, only 10–20% of …
(ICC)) are among the most frequent cancers worldwide. However, only 10–20% of …
[HTML][HTML] International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin …
Purpose A multidisciplinary expert panel convened to formulate state-of-the-art recommendations
for optimisation of selective internal radiation therapy (SIRT) with yttrium-90 ( 90 Y)-…
for optimisation of selective internal radiation therapy (SIRT) with yttrium-90 ( 90 Y)-…
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value
…, T de Groot, J Menten, P Flamen… - European journal of …, 2005 - Springer
Purpose 18 F-fluorodeoxyglucose (FDG) and 11 C-methionine (MET) PET imaging studies
allow the investigation of metabolism and amino acid transport in brain tumours. Their (…
allow the investigation of metabolism and amino acid transport in brain tumours. Their (…
Additional Value of Whole-Body Positron Emission Tomography With Fluorine-18-2-Fluoro-2-deoxy-d-glucose in Recurrent Colorectal Cancer
P Flamen, S Stroobants, E Van Cutsem… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: To assess the additional value of the whole-body [ 18 F]-2-fluoro-2-deoxy-d-glucose
positron emission tomography (FDG-PET) scan as a staging modality complementing …
positron emission tomography (FDG-PET) scan as a staging modality complementing …
18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo …
…, J Baselga, M Piccart, P Flamen… - Journal of Nuclear …, 2013 - Soc Nuclear Med
Molecular imaging receives increased attention for selecting patients who will benefit from
targeted anticancer therapies. Neo-ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab …
targeted anticancer therapies. Neo-ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab …
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin …
P Flamen, B Vanderlinden, P Delatte… - Physics in Medicine …, 2008 - iopscience.iop.org
Selective internal radiotherapy (SIRT) using Yttrium-90 labeled resin microspheres is
increasingly used for the radioembolization of unresectable liver metastases of colorectal cancer (…
increasingly used for the radioembolization of unresectable liver metastases of colorectal cancer (…